## Abstract ## Purpose The purpose of this study was to determine whether sonography (US) can usefully differentiate thyroid follicular adenoma (FA) and follicular carcinoma (FC). ## Methods This retrospective study included 60 pathologically proven FAs and 66 FCs in 123 consecutive patients (17
Chromosome imbalances in thyroid follicular neoplasms: A comparison between follicular adenomas and carcinomas
✍ Scribed by Lucia Roque; Raquel Rodrigues; António Pinto; Vasco Moura-Nunes; Jorge Soares
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 333 KB
- Volume
- 36
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The underlying genetic events associated with follicular thyroid tumorigenesis are still ill defined. In this study, we performed a screening for chromosome imbalances by comparative genomic hybridization (CGH) in a group of 12 follicular adenomas (FAs) and 20 follicular carcinomas (FTCs) previously characterized by conventional cytogenetics and flow cytometry analysis. In general, a great similarity was observed between the CGH profiles of the FAs and FTCs. In both benign and malignant tumors, a combination of gains affecting 5, 7, 12, 17, 19, and 20 was observed. Chromosome 7 was the most frequently affected chromosome, with three regions of consensus gains: 7p11–12, 7q11.3–q21, and 7q31. Recurrent gains of chromosomes 5 and 12 involved 5p11, 5p15, 5q13–q22, 5q21–q23, 12p11, and 12q11–q12. DNA sequence losses were also observed in both tumor groups. Chromosomal arms deleted in at least five of the neoplasms were (in order of frequency): in adenomas, 15q, 2p/2q, 3q, 6p/6q, 11q, and 22q; and in FTCs, 3p, 2p, 8q, 1p, 2q, 3q, 6q, 8p, 9p, 11q, 13q, 6p, and 18q. The statistical evaluation of the CGH data demonstrated that 15q loss was significantly associated with FA. Two regions of minimal common loss were defined by CGH at 15: 15q11–q21 and 15q26‐qter. The identification of these regions provides a basis for further molecular studies. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Purpose: To compare and contrast the clinical presentation and treatment outcome of patients with papillary and follicular thyroid carcinoma and to study the pattern of practice of treatment of differentiated thyroid carcinoma in hong kong. ## Method: The clinical presentation and treatment ou
## Abstract ## BACKGROUND Nodules of the thyroid gland are observed frequently in patients who undergo ultrasound studies. The majority of these nodules are benign, corresponding to goiters or adenomas, and only a small fraction corresponds to carcinomas. Among thyroid tumors, the diagnosis of fol
## Abstract The identification of molecular markers allowing to differentiate between benign and malignant thyroid tumors remains a diagnostic challenge. Herein, we have used the expression of the high mobility group protein gene __HMGA2__ and its protein, respectively, as a possible marker detecti
We report the cytogenetic analysis of a follicular thyroid carcinoma and its bone metastasis. Both lesions had identical chromosomal abnormalities, with a der(3)t(2;3)(q I3;p25) as the most likely primary clonal alteration. Our findings corroborate previous observations of frequent 3p deletions in t